GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » EV-to-FCF

Bharat Immunologicals & Biologicals (BOM:524663) EV-to-FCF : (As of Jun. 09, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bharat Immunologicals & Biologicals's Enterprise Value is ₹1,925.20 Mil. Bharat Immunologicals & Biologicals's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was ₹0.00 Mil. Therefore, Bharat Immunologicals & Biologicals's EV-to-FCF for today is .

The historical rank and industry rank for Bharat Immunologicals & Biologicals's EV-to-FCF or its related term are showing as below:

BOM:524663' s EV-to-FCF Range Over the Past 10 Years
Min: -9.91   Med: -5.58   Max: 26.13
Current: 18

During the past 13 years, the highest EV-to-FCF of Bharat Immunologicals & Biologicals was 26.13. The lowest was -9.91. And the median was -5.58.

BOM:524663's EV-to-FCF is ranked worse than
63.35% of 382 companies
in the Biotechnology industry
Industry Median: 8.405 vs BOM:524663: 18.00

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-09), Bharat Immunologicals & Biologicals's stock price is ₹28.62. Bharat Immunologicals & Biologicals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-4.178. Therefore, Bharat Immunologicals & Biologicals's PE Ratio for today is At Loss.


Bharat Immunologicals & Biologicals EV-to-FCF Historical Data

The historical data trend for Bharat Immunologicals & Biologicals's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bharat Immunologicals & Biologicals EV-to-FCF Chart

Bharat Immunologicals & Biologicals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.96 0.47 18.90 -4.62 15.13

Bharat Immunologicals & Biologicals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.01 - 15.13 - -

Competitive Comparison of Bharat Immunologicals & Biologicals's EV-to-FCF

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bharat Immunologicals & Biologicals's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's EV-to-FCF falls into.



Bharat Immunologicals & Biologicals EV-to-FCF Calculation

Bharat Immunologicals & Biologicals's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1925.202/0
=

Bharat Immunologicals & Biologicals's current Enterprise Value is ₹1,925.20 Mil.
Bharat Immunologicals & Biologicals's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bharat Immunologicals & Biologicals  (BOM:524663) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bharat Immunologicals & Biologicals's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=28.62/-4.178
=At Loss

Bharat Immunologicals & Biologicals's share price for today is ₹28.62.
Bharat Immunologicals & Biologicals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-4.178.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Bharat Immunologicals & Biologicals EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Traded in Other Exchanges
N/A
Address
Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines